Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Weak stock price reaction
View:
Post by SPCEO1 on Jul 13, 2022 12:16pm

Weak stock price reaction

Removing the threat of a nasty dilutive offering should have caused the stock price to jump considerably today. While the day is not over, it is clear no one is paying attention to what TH is up to by the low trading volume. Hopefully, this will highlight to management the enormity of their task to get THTX treated like most other small biotechs. When Paul first suggested a debt offering like this was a possibility he said a CEO friend of his at another biotech company saw their stock rise 30% or so on news of a similar offering.

The news today was very good, particularly in a very difficult biotech funding environment, but the stock's muted reaction shows few are paying any attention at all and that THTX still has a lot of distance to go to repair their relationships with investors.   

Hopefully, we will get additional good news tomorrow but it is going to take more than good news to get a better value on the share price if few are paying any attention to it. Correcting that needs to be a top priority and good clinical results in cancer should help if they can achieve them.
Comment by swetazo on Jul 13, 2022 2:46pm
This post has been removed in accordance with Community Policy
Comment by Lee430 on Jul 13, 2022 3:53pm
Pleeeeez Thera announces something tomorror so amazing that even Mr. Market can't ignore us any longer.
Comment by SPCEO1 on Jul 13, 2022 5:00pm
I am sure management expected a better price jump on today's news. Perhaps they will start getting serious about the huge hole they have dug for themselves in regards to the capital markets. You simply cannot ignore investors like TH has. The continued low volume today shows they have totally lost any consistent following for the stock other than us here on this board. Fortunately, it is ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities